Abstract:Background Although the sphingolipid metabolism pathway is known to play a significant role in tumor progression, there have been few studies on how genetic variants in the sphingolipid metabolism pathway genes affect the survival of patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Methods We utilized available genotyping data to conduct multivariate Cox proportional hazards regression model analysis, examining the associations of 12,188 single nucleotide polymorphisms (SNPs) in 86 sphingolipid metabolism pathway genes on the survival of 866 HBV-HCC patients, and the model was also used in additive interaction analysis. We used bioinformatics functional prediction and expression quantitative trait locus (eQTL) analysis to explore the potential functions of SNPs and to evaluate the association of SNPs with the corresponding mRNA expression, respectively. We also used the online database TIMER2.0 ( http://timer.comp-genomics.org/ ) to analyze the relationship between the corresponding mRNA expression levels and immune cell infiltration. Results Our study found that GBA2 rs1570247 G>A was significantly associated with elevated survival of HBV-HCC patients [(hazards ratio (HR ) =0.74, 95% confidence interval (CI ) =0.64-0.86, P <0.001)]. And on an additive scale, a synergistic effect was observed between the GG genotype of rs1570247 and advanced BCLC stage. Among HBV-HCC patients with advanced BCLC stage, those carrying the GBA2 rs1570247 GG genotype exhibited a significantly elevated risk of mortality (HR=3.32, 95%CI=2.45-4.50). Further functional prediction and eQTL analysis revealed that rs1570247 were located in the 5’ untranslated region of the GBA2 , the A allele of SNP rs1570247 was associated with higher mRNA expression levels of GBA2 in normal liver tissues ( P =0.009). Moreover, we observed a positive correlation between GBA2 mRNA expression and the infiltration level of B lymphocytes cell ( R =0.331, P <0.001), while a negative correlation was noted between GBA2 mRNA expression and the infiltration level of macrophage M2 in HCC ( R =-0.383, P <0.001). Conclusion Our findings suggest that GBA2 rs1570247 G>A in sphingolipid metabolism pathway may be a key factor for survival of HBV-HCC patients by regulating the expression of corresponding genes and affecting the infiltration level of immune cells.

Genetic Variants in Glucose-6-phosphate Isomerase Gene As Prognosis Predictors in Hepatocellular Carcinoma.

Genetic Variants in p53 Pathway Genes Affect Survival of Patients with HBV-Related Hepatocellular Carcinoma

Associations between genetic variants in sphingolipid metabolism pathway genes and hepatitis B virus-related hepatocellular carcinoma survival

Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma.

GGPPS1 Predicts the Biological Character of Hepatocellular Carcinoma in Patients with Cirrhosis

GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis

Phosphoglucose Isomerase Gene Expression As a Prognostic Biomarker of Gastric Cancer

Genetic Variants in the Hedgehog Signaling Pathway Genes Are Associated with Gastric Cancer Risk in a Chinese Han Population

Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma

Genetic Variations in Genes of Metabolic Enzymes Predict Postoperational Prognosis of Patients with Colorectal Cancer

PGK1 is a potential biomarker for early diagnosis and prognosis of hepatocellular carcinoma

Glycolysis-related Gene Expression Profiling Serves As a Novel Prognosis Risk Predictor for Human Hepatocellular Carcinoma

A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma

Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients

Caspase Polymorphisms and Prognosis of Hepatocellular Carcinoma

Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.

Prognostic significance of pyrimidine metabolism-related genes as risk biomarkers in hepatocellular carcinoma

The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis

Polymorphisms in POLG Were Associated with the Prognosis and Mtdna Content in Hepatocellular Carcinoma Patients.

A Genetic Variant in Large Tumor Suppressor Kinase 2 of Hippo Signaling Pathway Contributes to Prognosis of Hepatocellular Carcinoma.

Polymorphisms of HIF1A gene are associated with prognosis of early stage non-small-cell lung cancer patients after surgery